Kyoto University Hospital has succeeded in transplanting pancreatic cell sheets made from induced pluripotent stem (iPS) cells into a diabetic patient, achieving the first clinical application of such sheets in Japan.
Announcing the results Monday, the hospital said that the patient in her 40s has already been discharged with a favorable prognosis.
It was the first transplant surgery in the hospital's clinical trial for treating Type 1 diabetes through the transplantation of pancreatic cell sheets made from iPS cells.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.